MAY 23, 2019 11:29 PM PDT

Rapamycin and Anti-Aging

WRITTEN BY: Nouran Amin

Rapamycin was considered a wonder drug upon its discovery three decades ago when it was isolated from soil bacteria. It works as an immuno-suppressor in a variety of ways and has been to reduce immune responses in patients who received organ transplants. Now, rapamycin is garnering popularity again for its potential role in cancer therapy, neuroprotection, and most notably in anti-aging therapies.

Rapamycin inhibits cell growth by targeting mTOR--the master regulator of cell growth in our cells. The targeting of mTOR leads to autophagy, a process by which cellular lysosomes eradicate misfolded proteins and damaged organelles.

"The main function of the lysosome is to maintain the healthy state of the cell because it degrades the harmful stuff within the cell," said Xiaoli Zhang, a postdoctoral researcher in the University of Michigan Department of Molecular, Cellular and Developmental Biology. "During stress conditions, autophagy can lead to the cell survival by degrading dysfunctional components and providing the building blocks of cells, such as amino acids and lipids."

Now, new research points to more than one cellular pathway being targeted by the rapamycin such pathway involves a calcium ion channel on the lysosomal membrane known as TRPML1 and is critical in regulating lysosomal function. "Without this channel, you get neurodegeneration," said Haoxing Xu, principal investigator of the study. "If you stimulate the channel, it's anti-neurodegeneration."

Findings were published in PLOS Biology.

"We think lysosomal TRPML1 may contribute significantly to the neuroprotective and anti-aging effects of rapamycin," says lead author Wei Chen, who worked on investigating TRPML1 by using a unique technique called a lysosome patch clamp. "The identification of a new target of rapamycin offers an insight in developing the next generation of rapamycin, which will have a more specific effect on neurodegenerative disease."

Source: Medical Xpress

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
APR 11, 2020
Cancer
APR 11, 2020
The Mice Make the Difference in CAR-T Studies
It is quite common in cancer therapies to see a drug or treatment that has been around for decades. New drugs are hard t ...
APR 23, 2020
Cancer
APR 23, 2020
Doctors, watch out for unexpected side effects in small clinical trials
Doctors who have patients in small-sized clinical trials that test new cancer drugs should be on the look-out for unexpe ...
APR 22, 2020
Drug Discovery & Development
APR 22, 2020
Using Colors To Track The Spread of Drug Particles
Forensic scientists from the National Institute of Standards and Technology (NIST) are relying on color to see the sprea ...
MAY 04, 2020
Immunology
MAY 04, 2020
GeoVax and Sino Bio Collaborate on COVID-19 Vaccine Work
GeoVax Labs, Inc., a biotechnology company developing human vaccines and immunotherapies against infectious diseases and ...
MAY 08, 2020
Drug Discovery & Development
MAY 08, 2020
Cholesterol Drugs May Boost Healthy Gut Bacteria in Obese People
While statins have long been known for their efficacy in treating high cholesterol, until recently, there was no evidenc ...
MAY 16, 2020
Neuroscience
MAY 16, 2020
Stem Cell Method (Parkinson's) Could Avoid Transplant Rejection
Researchers at McLean Hospital and Massachusetts General Hospital (MGH) have tested a stem cell treatment method that av ...
Loading Comments...